文章(zhang)來(lai)源(yuan)：華潤（集團(tuan)）有(you)限(xian)公司 發(fa)布時間(jian)：2009-08-26
華(hua)潤(run)集團(tuan)旗下三九醫藥股份有限公(gong)司(si)發布2008年半(ban)年度(du)報告(gao)(gao)，公(gong)司(si)實現營業收入19.10億(yi)元(yuan)，同(tong)比增長(chang)19.94％；營業利潤(run)2.77億(yi)元(yuan)，同(tong)比增長(chang)116.55％；歸屬(shu)于母(mu)公(gong)司(si)的(de)凈利潤(run)為2.09億(yi)元(yuan)，同(tong)比增長(chang)122.95％；實現每(mei)股收益0.21元(yuan)。公(gong)告(gao)(gao)還稱，經(jing)財務部門初步(bu)測算(suan)，預計今年前九個(ge)月，實現的(de)歸屬(shu)于母(mu)公(gong)司(si)所有者的(de)凈利潤(run)與上年同(tong)期(qi)相比增長(chang)100%-150%。
今年上半(ban)年，三九醫藥(yao)股(gu)份公司醫藥(yao)工業收入同(tong)(tong)(tong)(tong)比(bi)(bi)增長(chang)(chang)23.72%，其中(zhong)(zhong)OTC銷(xiao)(xiao)售(shou)額(e)同(tong)(tong)(tong)(tong)比(bi)(bi)增長(chang)(chang)14%，中(zhong)(zhong)藥(yao)處方(fang)藥(yao)銷(xiao)(xiao)售(shou)額(e)同(tong)(tong)(tong)(tong)比(bi)(bi)增長(chang)(chang)50%，抗生(sheng)素(su)及原(yuan)料藥(yao)銷(xiao)(xiao)售(shou)額(e)同(tong)(tong)(tong)(tong)比(bi)(bi)增長(chang)(chang)66%，延續了較快的(de)增長(chang)(chang)勢頭，免(mian)煎中(zhong)(zhong)藥(yao)銷(xiao)(xiao)售(shou)額(e)同(tong)(tong)(tong)(tong)比(bi)(bi)增長(chang)(chang)55%。產品方(fang)面，主打(da)產品感冒靈銷(xiao)(xiao)售(shou)同(tong)(tong)(tong)(tong)比(bi)(bi)增長(chang)(chang)26%，達(da)到2.65億元；皮炎平(ping)軟膏銷(xiao)(xiao)售(shou)達(da)到2.46億元，同(tong)(tong)(tong)(tong)比(bi)(bi)增長(chang)(chang)12.60%，參(can)附(fu)及生(sheng)脈(mo)銷(xiao)(xiao)售(shou)分(fen)別增長(chang)(chang)52%及230%，三九皮炎平(ping)、三九胃(wei)泰保(bao)持平(ping)穩；新產品小兒感冒靈、復方(fang)氨酚烷胺(an)、無水頭孢唑(zuo)林鈉等增長(chang)(chang)快速(su)。